Franco Locatelli

Employment

• Catholic University of the Sacred Heart Full Professor of Pediatrics
  2022 - Present

Education

• Università degli Studi di Pavia Medical Doctor

Projects & Funding

Projects & funding information is unavailable.

Publications (50)

• Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia
  New England Journal of Medicine 2023 DOI: 10.1056/NEJMoa2214171
  +Save
• The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children
  Journal of Clinical Medicine 2023 DOI: 10.3390/jcm12062149
  +Save
• Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
  Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari +19 more
  Leukemia 2023 DOI: 10.1038/s41375-022-01770-3
  +Save
• Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia
  Pediatric Blood & Cancer 2022 DOI: 10.1002/pbc.29999
  +Save
• Asplenia and spleen hypofunction
  Nature Reviews Disease Primers 2022 DOI: 10.1038/s41572-022-00399-x
  +Save
• Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms232113458
  +Save
• UNCAN.eu, a European Initiative to UNderstand CANcer
  Cancer Discovery 2022 DOI: 10.1158/2159-8290.CD-22-0970
  +Save
• ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature
  Biomolecules 2022 DOI: 10.3390/biom12081142
  +Save
• Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia
  Pediatric Blood & Cancer 2022 DOI: 10.1002/pbc.29715
  +Save
• Characterization of KIR+NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
  HLA 2022 DOI: 10.1111/tan.14640
  +Save
• Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH
  Blood 2022 DOI: 10.1182/blood.2021013549
  +Save
• Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group
  Biomedicines 2022 DOI: 10.3390/biomedicines10071530
  +Save
• Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells
  British Journal of Haematology 2022 DOI: 10.1111/bjh.18012
  +Save
• Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real‐world setting: Results from the NEUF study
  Pediatric Blood & Cancer 2022 DOI: 10.1002/pbc.29562
  +Save
• Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma
  European Journal of Cancer 2022 DOI: 10.1016/j.ejca.2021.12.029
  +Save
• A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children
  Pediatric Research 2021 DOI: 10.1038/s41390-020-1065-5
  +Save
• A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
  Blood 2021 DOI: 10.1182/blood.2020007848
  +Save
• ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
  Genome Biology 2021 DOI: 10.1186/s13059-021-02271-9
  +Save
• AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
  Emiliano Maiani, Giacomo Milletti, Francesca Nazio +43 more
  Nature 2021 DOI: 10.1038/s41586-021-03422-5
  +Save
• Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III
  Blood Advances 2021 DOI: 10.1182/bloodadvances.2020002185
  +Save